Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04131543
Title Phase II Study With Cabozantinib in Patients With RET Positive NSCLC (CRETA)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Bologna
Indications

lung non-small cell carcinoma

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST